We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 13,739

Fourth Circuit Flubs Admissibility of 510k Clearance
  • Dechert LLP
  • USA
  • February 11 2016

We’ve put it off long enough - time to deal with the awful decision in C.R. Bard v. Cisson, __ F.3d __, 2016 WL 158814 (4th Cir. Jan. 14, 2016). When


FDA Panel Shows Strong Support for a Remicade Biosimilar
  • Foley & Lardner LLP
  • USA
  • February 11 2016

The Food and Drug Administration's (FDAs) Arthritis Advisory Committee gave a thumbs up to a biosimilar copy of Johnson & Johnson's Remicade product


FDA Unveils Action Plan to Combat Opioid Abuse
  • Foley & Lardner LLP
  • USA
  • February 11 2016

The U.S. Food and Drug Administration ("FDA") recently announced a "far-reaching action plan" to evaluate and improve the agency's prescription


FDA Issues Guidance on Cybersecurity Issues for Postmarket Medical Devices
  • Baker & Hostetler LLP
  • USA
  • February 11 2016

On January 22, 2016, the Food and Drug Administration (FDA) issued draft guidance on cybersecurity risks associated with medical devices, and


Three Signs Your Native Ad Needs a Disclosure: The FTC Issues Native Advertising Guidelines
  • Hogan Lovells
  • USA
  • February 10 2016

If you've ever opened your washing machine to find white socks turned a pale shade of pink, you can relate to the sentiment of Buzzfeed UK's piece


State Law Claims Against Generic Drug Manufacturer Cannot Escape Mensing Preemption in 7th Circuit
  • Weil Gotshal & Manges LLP
  • USA
  • February 10 2016

Despite a myriad of decisions permitting state-law claims to proceed against generic drug manufacturers following the U.S. Supreme Court's decision in


Labels - a necessary pain in the neck
  • Foster Swift Collins & Smith PC
  • USA
  • February 10 2016

If you manufacture, import, sell, offer to sell, or distribute garments or textiles for household use, you need to know about labels. If you don’t


Hot Topics on the Agenda for House Committee Hearing on CPSC
  • Husch Blackwell LLP
  • USA
  • February 9 2016

As previously discussed here, the U.S. House of Representatives Energy & Commerce Committee will hold a hearing entitled "Industry Perspectives on


Chobani Yogurt Ad Campaign Enjoined - A Healthy Result for Yoplait and Dannon
  • Dorsey & Whitney LLP
  • USA
  • February 9 2016

When I opened up a newspaper a few weeks ago and saw an ad by Chobani for its Simply 100 Greek Yogurt, my first thought was, “that’s going to provoke


AbbVie Submits Citizen Petition on Interchangeable Biosimilars
  • Patterson Belknap Webb & Tyler LLP
  • USA
  • February 9 2016

AbbVie, Inc., a biopharmaceutical company, has submitted a citizen petition to the FDA regarding determinations of interchangeability under the BPCIA